Still very cheap around this price. Worst is behind them now. Only wish they didn't confuse building their own software and operating an outsourced service. Two very different things.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025